Skip to main content

Table 3 One-year outcomes of the patients with CVSS post-stenting after underwent OACs plus antiplatelet or dual antiplatelet

From: Safety and efficacy comparison between OACs plus single antiplatelet and dual antiplatelet therapy in patients with cerebral venous sinus stenosis poststenting

Items

OACs plus antiplatelet (n = 52)

Dual antiplatelet (n = 58)

p-value

Major bleeding events, n (%)

0 (0.0)

0 (0.0)

NA

Minor bleeding events, n (%)

0 (0.0)

2 (3.4)

0.497

VTEs, n (%)

0 (0.0)

0 (0.0)

NA

Intraluminal restenosis

0 (0.0)

1(1.7)

1.000

In-stent thrombosis

0 (0.0)

2 (3.4)

0.497

Stent-adjacent stenosis

0 (0.0)

0 (0.0)

NA

Stent displacement

0 (0.0)

0 (0.0)

NA

  1. Abbreviations: OACs direct oral anticoagulants, VTEs venous thrombotic events; Data were presented as n (%), mean ± SD or median (interquartile range). NA Not applicable